The synthesis of N-acetylneuraminate (Neu5Ac), the main form of sialic acid, proceeds in vertebrates through the condensation of N-acetylmannosamine 6-phosphate and phosphoenolpyruvate to Neu5Ac-9-phosphate, followed by the dephosphorylation of the latter by a specific phosphatase. The sequence encoding Neu5Ac-9-phosphate phosphatase (Neu5Ac-9-Pase; E.C. 3.1.3.29) has not been determined until now. In the present work, we have purified Neu5Ac-9-Pase more than 1000-fold from rat liver. Its dependency on Mg 2+ and the fact that it was inhibited by vanadate and Ca 2+ suggested that it belonged to the haloacid dehalogenase family of phosphatases. Trypsin digestion and mass spectrometry analysis of a polypeptide of ≈ 30 kDa that co-eluted with the activity in the last purification step indicated the presence of a protein designated 'Haloacid dehalogenase-like hydrolase domain containing 4'. The human orthologue of this protein is encoded by a 2-exon gene present on chromosome 20p11. The human protein was overexpressed in E. coli as a fusion protein with a polyHis tag and purified to homogeneity. The recombinant enzyme displayed a > 230-fold higher catalytic efficiency on Neu5Ac-9-phosphate than on its second best substrate. Its properties were similar to those of the enzyme purified from rat liver. Neu5Ac inhibited the enzymatic activity by 50% at 15 mM, indicating that no significant inhibition is exerted at physiological concentrations of Neu5Ac. The identification of the gene encoding Neu5Ac-9-Pase will facilitate studies aimed at testing its potential implication in unexplained forms of glycosylation deficiency.
Results

Purification and identification of N-acetylneuraminate-9-phosphate phosphatase
Neu5Ac-9-Pase was substantially purified from rat liver by a procedure involving chromatographic steps on DEAE-Sepharose, Phenyl-Sepharose, Sephacryl S-200 and UnoQ (a high resolution anion exchanger gel). The phosphatase activity was followed during the purification by measuring the release of [ 32 P]Pi from [ 32 P]Neu5Ac-9-P. The phosphatase was eluted as a single peak in each of the purification steps, indicating the presence of a single enzyme species. This is illustrated in Figure 1 for the DEAE-Sepharose column, which allowed the separation of Neu5Ac-9-Pase from Neu5Ac-9-P synthase. The overall yield of the purification was rather low (0.8%, Table I ), but this was due to the fact that only the most active fractions were used after each step of the purification procedure.
SDS-PAGE analysis of the fractions of the UnoQ column revealed the presence of several polypeptides in the most purified preparation (Figure 2 ). Three of them, which coeluted best with the enzymatic activity, were cut out of the gel and digested with trypsin. The resulting tryptic peptides were sequenced by tandem mass spectrometry. This led to the identification of band 1 as dihydrodiol dehydrogenase (gi-15208398), band 2 as alphatocopherol transfer protein (gi-6981682) and band 3 as a mixture of 6-phosphogluconolactonase (gi-13384778) and a rat protein of unknown function annotated as 'haloacid dehalogenase-like hydrolase domain containing 4 (HDHD4)' (gi-57863283), a protein with a predicted molecular mass of 27.8 kDa. The peptides that led to the identification of this protein are underlined in the sequence shown in Figure 3 .
As the haloacid dehalogenase family of proteins comprises a series of phosphatases (Aravind et al., 1998; Collet et al., 1998) , HDHD4 was an interesting candidate. BLAST searches indicated the presence of proteins sharing a high degree of identity with rat HDHD4
in man and other mammals (88-97% identity), Gallus gallus (71%), Xenopus laevis (59%), fishes (47-49%) and insects (32-36% is encoded by a 2-exon gene (gi-23308749) present on chromosome 20p11. The alignment in Figure 3 shows that the HDHD4 orthologues shared the three motifs found in phosphatases of the HAD family, namely a first motif comprising two extremely conserved aspartates, a second motif comprising a conserved serine or threonine, and a third motif comprising a conserved lysine and two conserved aspartates. The first aspartate in the first motif forms a phosphoaspartate during the catalytic cycle (Collet et al., 1998) . These findings suggested therefore that the HDHD4 protein was a phosphatase.
Phosphatases of the HAD family have a set of kinetic characteristics that distinguish them from other phosphatases. Like all enzymes that form a phosphoenzyme during the catalytic cycle, they are inhibited by vanadate (Macara, 1980) . Furthermore, their activity is dependent on the presence of Mg 2+ (Collet et al., 1999; Selengut et al., 2000) , which plays a critical role in catalysis (Ridder et al., 1999; Peeraer et al., 2004) . Finally, Ca 2+ inhibits their activity by replacing Mg 2+ and preventing the nucleophilic attack by the aspartate that covalently binds the phosphate group (Peeraer et al., 2004) . We therefore tested these properties on our partially purified Neu5Ac-9-Pase, assayed with a concentration of 50 µM Neu5Ac-9-P. The activity of the enzyme was found to be totally dependent on the presence of
Mg
2+
, which half-maximally activated the enzyme at 100 µM. Vanadate and Ca 2+ both inhibited the enzyme, causing 50% inhibition at 12 µM and 450 µM, respectively. These findings agreed with the idea that Neu5Ac-9-Pase was a phosphatase of the HAD family and that it presumably corresponded to HDHD4.
The K m of rat liver Neu5Ac-9-Pase was also determined. A value of 430 µM was obtained. We also tested the effect of Neu5Ac on Neu5Ac-9-Pase. In the presence of 50 µM or 250 µM substrate, 50% inhibition was reached at 15 mM Neu5Ac.
Expression and characterization of recombinant human N-acetylneuraminate-9-phosphate phosphatase
In order to confirm the identity of the phosphatase purified from rat liver, human HDHD4 was expressed in Escherichia coli as a fusion protein with a N-terminal polyhistidine. SDS-PAGE analysis showed that extracts from bacteria that had been cultured for 16 h at 22°C in the presence of the inducer IPTG contained a soluble polypeptide of ≈ 30 kDa (not shown), which was absent from non-induced cells (not shown). The recombinant protein was purified to homogeneity by affinity chromatography on Ni 2+ -agarose gel (not shown). Using this procedure, 1.4 mg of pure enzyme was obtained from a 500 ml culture.
The purified recombinant protein catalysed the dephosphorylation of Neu5Ac-9-P with a K m of 90 µM and a V max of 112 µmol/min/mg protein. As shown in Table II , it also dephosphorylated other compounds, but with a catalytic efficiency that was at least 200-fold lower, and for most of them more than 10,000-fold lower. Interestingly, the second and third best substrates (fructose 1,6-bisphosphate and 6-phosphogluconate) were, like Neu5Ac-9-P, rather bulky compounds with a negatively charged function on their first carbon.
Like for the rat liver enzyme, the activity of human recombinant Neu5Ac-9-Pase was dependent on Mg 2+ and inhibited by vanadate (50% inhibition at 19 µM vanadate) and Ca 2+ .
As shown in Figure 4 , the inhibition exerted by the latter was competitive with Mg 2+ . Like for the rat liver enzyme, Neu5Ac caused a 50% inhibition at ≈ 15 mM Neu5Ac. We report in the present paper the identification of HDHD4, a member of the haloacid dehalogenase family of proteins, as Neu5Ac-9-Pase. This identification was based on the findings that the enzyme purified from rat liver co-eluted with a polypeptide with a similar molecular mass as HDHD4 and comprising peptides corresponding to HDHD4. This was confirmed by the observation that purified recombinant HDHD4 acted as a Neu5Ac-9-Pase with a catalytic efficiency that was more than two orders of magnitude higher than for any other substrate that was tested. Furthermore, the recombinant protein displayed kinetic characteristics that were similar to those of the enzyme purified from rat liver. This includes dependency on Mg 2+ and sensitivity to inhibition by vanadate and by Ca 2+ . The specific activity of the recombinant pure enzyme (≈ 110 U/mg protein) was about 150-fold higher than that of our most purified preparation, indicating that the latter was still quite impure, in agreement with the results of the SDS-PAGE analysis. The fact that the specific activity of the pure enzyme is about 195,000-fold higher than that of a crude liver extract indicates that Neu5Ac-9-Pase is a minor protein in rat liver.
Reaction mechanism and inhibition by Ca
2+
Like many phosphatases acting on low-molecular-weight substrates, Neu5Ac-9-Pase belongs to the HAD family. This is indicated by the presence of the three characteristic motifs found in phosphatases of this family. The first one comprises a DXDXT/V sequence (DLDNT in the present case), the first aspartate of which has been shown to be phosphorylated in phosphoserine phosphatase and phosphomannomutase (Collet et al., 1998) . Neu5Ac-9-Pase proceeds most likely also via a phosphoenzyme mechanism, as suggested by its sensitivity to vanadate (Macara, 1980) and by the conservation of the phosphorylatable aspartate close to its amino terminus.
Like phosphoserine phosphatase, Neu5Ac-9-Pase is inhibited by Ca
. Structural studies have recently allowed to rationalize this effect (Peeraer et al., 2004) . In phosphoserine phosphatase, Mg 2+ binds to the phosphate group of the substrate, to Asp179 (human phosphoserine phosphatase) and to only one of the oxygens of the ß-carboxyl group of the first aspartate of the DXDXT motif (Asp20). This allows the other oxygen of the ß-carboxyl group of Asp20 to adopt the appropriate orientation for attacking the phosphorus of the phosphate group. Because of its larger ionic radius, Ca 2+ binds to both oxygens of the carboxyl group of Asp20, making that the carboxyl oxygen that normally should attack the phosphate is too far away from the phosphate group and not appropriately oriented to perform a nucleophilic attack. Due to the high conservation of the residues that participate in catalysis in all phosphatases of the HAD family, it is likely that this sensitivity to Ca 2+ is shared by all members of this family, as we show indeed this to be the case for Neu5Ac-9-Pase. It should be stressed that, at physiological concentrations of Mg 2+ (of the order of 1 mM), the inhibition requires concentrations of Ca 2+ that are several orders of magnitude higher than the physiological cytosolic concentrations of this divalent cation.
In vivo regulation of N-acetylneuraminate-9-phosphate phosphatase
The activity of phosphoserine phosphatase, another enzyme of the HAD family, is inhibited by physiological concentrations of the reaction product L-serine, which acts as a feedback inhibitor in mammalian cells (Snell, 1984) . Our results indicate that, in marked contrast, Neu5Ac-9-Pase is only poorly inhibited by its product Neu5Ac. The physiological concentration of the latter is indeed of the order of 100 µM (Ferwerda et al., 1983) whereas 50% inhibition of the enzymatic activity was observed at ≈ 15 mM Neu5Ac. This is consistent with the fact that sialuria is due to mutations in the bifunctional enzyme UDP-Nacetylglucosamine-2-epimerase/N-acetylmannosamine kinase that abolish the inhibition exerted by CMP-Neu5Ac (Seppala et al., 1991; . If feedback inhibition by sialic acid was also exerted at the level of Neu5Ac-9-Pase, mutations that abolish the allosteric 
Distribution of N-acetylneuraminate-9-phosphate phosphatase in nature
As schematised in Figure 5 , bacteria make Neu5Ac directly through the condensation of Nacetylmannosamine with phosphoenolpyruvate (Vann et al., 1997; Ringenberg et al., 2003) , whereas mammals form it from N-acetylmannosamine 6-phosphate via Neu5Ac-9-P as an intermediate (Watson et al., 1966) . Since the enzymes catalysing the formation of Neu5Ac-9-P in mammals and Neu5Ac in bacteria are homologous (Lawrence et al., 2000) , the presence of a Neu5Ac/Neu5Ac-9-P synthase homologue in a given species does not allow one to conclude whether the synthesis of sialic acid proceeds in this species from phosphorylated or non-phosphorylated N-acetylmannosamine. The presence of a protein sharing at least ≈ 50% sequence identity with rat or human Neu5Ac-9-Pase in the genomes of mammals, chicken, xenopus and fishes indicates that sialic acid synthesis proceeds via the 9-phosphate intermediate in these species. This is consistent with the finding that the genome of vertebrates comprises a gene encoding the bifunctional enzyme UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase, which provides the required N-acetylmannosamine 6-phosphate. This bifunctional enzyme is missing in insects, whereas the Neu5Ac/Neu5Ac-9-P synthase homologue is present and has been demonstrated to form Neu5Ac-9-P from Nacetylmannosamine 6-phosphate, as well as 2-keto-3-deoxy-D-glycero-D-galacto-nononate 9-phosphate (KDN-9-P) from mannose 6-phosphate (Kim et al., 2002) . The finding that insect cells form Neu5Ac when they are supplemented with N-acetylmannosamine (Kim et al., 2002) or transfected with the mammalian bifunctional enzyme (Viswanathan et al., 2003) suggests that the Neu5Ac-9-Pase homologue of insects may act indeed to dephosphorylate finding that mammalian cells convert N-acyl modified analogues of mannosamine to sialic acid derivatives that are incorporated in sialoglycoconjugates (Keppler et al., 2001) .
One may wonder why sialic acid synthesis proceeds through a 9-phospho-intermediate in vertebrates (Watson et al., 1966) but not in bacteria (Vann et al., 1997; Ringenberg et al., 2003) . This may have to do with the existence of different enzymes for the catabolism of Nacetylmannosamine. In higher eukaryotes, an epimerase converts non-phosphorylated Nacetylmannosamine to N-acetylglucosamine (Ghosh and Roseman, 1965) . The catabolic role of this enzyme has been demonstrated by showing that its overexpression reduces the formation of sialic acid in Jurkat cells (Luchansky et al., 2003) . In marked contrast, Nacetylmannosamine degradation in bacteria involves its phosphorylation to Nacetylmannosamine 6-phosphate, which is then converted to N-acetylglucosamine 6-phosphate by a specific epimerase, encoded by the nanE gene (Plumbridge and Vimr, 1999; Walters et al., 1999) . It may therefore be advantageous for vertebrates to catalyse the phosphorylation of N-acetylmannosamine as soon as it is formed, to avoid its conversion to N-acetylglucosamine and minimize a futile cycle that costs 2 high-energy bonds per cycle. On the opposite, avoiding the phosphorylation of N-acetylmannosamine precludes its degradation by nanE in bacteria.
Implications for the study of glycosylation defects
As mentioned in the Introduction, glycosylation defects are an expanding group of disorders, which generally lead to multiorgan involvement. Nearly 20 enzyme or transporter deficiencies have been identified thanks to a combination of enzyme activity analysis, functional assays of protein glycosylation in fibroblasts and mutation search in the relevant genes (Jaeken and Carchon, 2004) . However, many cases of glycosylation defects remain unsolved and it is likely that some of them are due to Neu5Ac-9-Pase deficiency. In principle, Neu5Ac-9-Pase deficiency should be identifiable through analysis of the Neu5Ac-9-Pase activity in fibroblasts or other cell types. However, the Neu5Ac-9-Pase assay requires a non-commercially available Furthermore, a common observation made with glycosylation defects is that the enzyme deficiencies underlying the affection are usually only partial (Grunewald et al., 2001) , consistent with glycosylation being indispensable for life. It is therefore likely that Neu5Ac-9-Pase deficiency, if it exists in patients, is incomplete. The identification of mutations in Neu5Ac-9-Pase gene and the testing of their effect on the enzymatic activity would be particularly important to establish that the glycosylation defect is indeed due to a Neu5Ac-9-Pase deficiency. 
Materials and methods
Materials
Synthesis of N-acetylneuraminate 9-phosphate
Mannosamine 6-phosphate was synthesized by incubating mannosamine (20 mM) for 6 h at 37°C with yeast hexokinase (14 U/ml) in the presence of 50 mM Hepes, pH 8, 25 mM ATPMg, 1 mM DTT, 100 µg/ml bovine serum albumin. The reaction mixture was heated at 90°C
for 5 min and centrifuged. The supernatant was brought to pH 8 with NaOH and incubated with 500 mM acetic anhydride for 50 min at 20°C. The resulting N-acetylmannosamine 6-phosphate was purified by anion-exchange chromatography on Dowex 1-X8 (Cl -) and gel filtration on Biogel P2 fine column (0.9 x 50 cm) equilibrated with water. Its titre was determined by measuring the inorganic phosphate (Fiske and Subbarow, 1925) Neu5Ac-9-P was synthesized by incubating 2.5 mM N-acetylmannosamine 6-phosphate with 40 mM Hepes, pH 7.4, 12.5 mM MgCl 2 , 1 mM MnCl 2 , 5 mM phosphoenolpyruvate and 5 mU/ml Neu5Ac-9-P synthase (partially purified from rat liver, see Figure 1 ) for 2 h at 37°C in a final volume of 10 ml. The reaction was stopped by adding at Pennsylvania State University on February 20, 2013
http://glycob.oxfordjournals.org/ Downloaded from 2.5 ml of ice-cold 10% (w/v) HClO 4 . After neutralization with K 2 CO 3 and elimination of the precipitate by centrifugation, the preparation was diluted to 100 ml with water and applied on an anion-exchange column (Dowex 1-X8 Cl -resin, 12 ml). The column was washed with 30 ml water, and a linear NaCl gradient (0-500 mM in 200 ml) was applied to elute the phosphate esters (assayed as the inorganic phosphate liberated by alkaline phosphatase). After concentration to 1.5 ml, the Neu5Ac-9-P preparation (17.5 µmol in total) was freed from
NaCl by gel-filtration on a Biogel P2 fine column (0.9 x 50 cm) and concentrated to 1 ml. The preparation was stored at -20°C. Radiolabelled [ 32 P]Neu5Ac-9-P was similarly prepared from 5 x 10 8 cpm [ 32 P]N-acetylmannosamine 6-phosphate in a final volume of 3 ml and was purified by anion-exchange chromatography.
Purification of N-acetylneuraminate-9-phosphate phosphatase
All purification steps were performed at 4°C and the enzymatic preparations were stored on ice between steps. Protein concentration was estimated either by measuring A 280 or by the Bradford assay using bovine serum albumin as a standard (Bradford, 1976) . The livers of 8 male, ≈ 400 g rats were homogenized in 3 volumes (w/v) of buffer A (25 mM Hepes, pH 7.1, 5 µg/ml leupeptin, 5 µg/ml antipain, 1 mM DTT and 25 mM KCl). The homogenate was centrifuged for 30 min at 16,000 x g. NaCl and poly(ethylene glycol) 6000 were added to the extract (350 ml) at final concentrations of 50 mM NaCl and 6% (w/v), respectively. The preparation was stirred on ice for 30 min and centrifuged for 30 min at 16,000 x g. The resulting supernatant (300 ml) was diluted 7-fold with buffer A and loaded on a BlueSepharose column (125 ml, equilibrated with buffer A), on which the phosphatase activity was not retained (this step was included to permit the purification of another, unrelated enzyme that was retained on the Blue-Sepharose column). The flow-through (≈ 2 l) was applied on a DEAE-Sepharose column (110 ml) equilibrated with buffer A. This column was washed with 400 ml of the same buffer before application of a NaCl gradient (0-0.5 M in 725 ml).
The active fractions from two such preparations were pooled and divided in three equal parts. Each of these parts (about 45 ml) was supplemented with solid NaCl to reach a final concentration of 3 M and applied on a Phenyl-Sepharose column (8.5 ml) equilibrated with buffer B (25 mM Hepes, pH 7.4, 5 µg/ml leupeptin, 5 µg/ml antipain and 1 mM DTT)
containing 3 M NaCl. The column was washed with 20 ml of the same buffer, and retained protein was eluted with a linear decreasing gradient of NaCl (3-0 M in 100 ml). The active fractions from the 3 columns were pooled (42 ml) and concentrated to 5 ml in an Amicon cell equipped with a 10 kDa cut-off membrane. This sample was loaded onto a 1.6 cm x 60 cm Sephacryl S-200 column equilibrated with 25 mM Hepes, pH 7.4, 100 mM NaCl, 1 mM DTT, 5 µg/ml leupeptin, 5 µg/ml antipain. Two fractions containing Neu5Ac-9-Pase activity were pooled, diluted in 5 ml of buffer B and loaded on an UnoQ (1 ml) column equilibrated in buffer B. After washing (3 column volumes), retained protein was eluted with a NaCl gradient (0-350 mM in 15 ml), and 0.5 ml fractions were collected for activity measurement and SDS-PAGE analysis.
Protein identification by mass spectrometry
In-gel tryptic digestions of protein bands and desalting of the peptides were performed as described (Foultier et al., 2003) . Peptides were analysed by nanoelectrospray ionisationtandem MS (MS/MS) in a LCQ Deca XP Plus ion trap mass spectrometer (ThermoFinnigan) fitted with a nanoelectrospray probe. The data were analysed with the X-calibur software (ThermoFinnigan) and the proteins were identified with TurboSEQUEST in the BioWorks software suite (ThermoFinnigan).
Overexpression and purification of human N-acetylneuraminate-9-phosphate phosphatase
A 5' primer containing the putative ATG codon (CCATATGGGGCTGAGCCGCGTGC) in an NdeI site (in bold) and a 3' primer containing the putative stop codon 16 adding 1 volume of 10% (w/v) ice-cold trichloroacetic acid. The mixture was centrifuged for 10 min at 16,000 x g at 4°C. The released [ 32 P]Pi was measured in the supernatant by extraction as a phosphomolybdate complex (McClard, 1979) . The kinetic properties were determined on the rat liver enzyme purified up to the Phenyl-Sepharose step or on the homogeneous recombinant human enzyme. Care was taken to use enzyme dilutions and incubation times for which no more than 25% of the substrate was consumed. Under these conditions, the production of substrate was linear with time and proportional to the concentration of enzyme. One unit of enzyme is the amount that catalyses the conversion of one µmol/min under the specified assay conditions. Neu5Ac-9-P synthase was assayed as described by Chen et al. (2002) . A liver preparation containing 20 g protein was applied on a DEAE-Sepharose column as described in Materials and Methods. Fractions of 6 ml were collected. The activities of Neu5Ac-9-Pase and Neu5Ac-9-P synthase (Chen et al., 2002) were determined. Protein was assayed with the Bradford assay. The NaCl gradient is also shown. Homo sapiens (Hsap, gi-23308749) , Xenopus laevis (Xlae, gi-46250196) , Danio rerio (Drer, gi-63101958) , and Drosophila melanogaster (Dmel, gi-28381565) . Only the first 280 residues of the latter sequence are shown. Completely conserved residues are shown in bold. The underlined residues correspond to the peptides identified by mass spectrometry. Asterisks indicate the extremely conserved residues in phosphatases of the HAD family (see text). 
